Injection solution Composition:
Injection solution: 2.2 ml cont.: Methylglyoxalum D10, Glyoxalum D10 22 µl each. Indications:
Stimulation of the defensive mechanisms against toxins in blocked and defective enzymatic systems, disturbed glandular functions; degenerative diseases (cellular phases).
In general, 1 ampoule i.m., s.c., i.d., i.v., 1-3 times weekly.
If the patient briefly experiences temperature rise or local pain after administration, this should be interpreted as a positive response to therapy. These reactions should, however, be allowed to subside before repeated injection.
Packs containing 5, 10, 50 and 100 ampoules of 2.2 ml.
Pharmacological and clinical notes
Methylglyoxalum (methyl glyoxal)
In cellular phases, particularly degeneration and neoplasm phases.
Has an activating effect on damaged respiratory enzymes; in all cellular phases, particularly neoplasm phases, and virus diseases.
Glyoxal compositum contains methyl glyoxal and oxalaldehyde which, according to Professor W. Frederik Koch, have a far-reaching action on the widest variety of degenerative diseases.
According to Professor Koch, methyl glyoxal and oxalaldehyde, as members of what is known as the carbonyl group series, have the property of deblocking blocked energy- producing systems of the cells, as well, by way of depolymerization of homotoxins and carcinotoxins, as dissolving a cancerous formation already in progress, by means of the action of the free radicals, which is possible both through quinones and through free carbonyl groups. In this way, through the free carbonyl groups and quinones, by means of hydrogen removal, the impregnation phase, to some extent, is broken up therapeutically. It has proved beneficial, in treatment with Glyoxal compositum, to interpose preparations such as Coenzyme compositum, Ubichinon compositum, Thyreoidea compositum etc., or to administer them in succession.
Also Hepar compositum (stimulation of the detoxicating hepatic function) can be interposed advantageously, while in cases of powerful regressive vicariation and the appearance of inflammatory symptoms, Traumeel S and Echinacea compositum S are indicated. Cancer therapy is based, among other preparations, on Viscum compositum (medium, forte), Coenzyme compositum ampoules, Ubichinon compositum ampoules, Galium-Heel, Psorinoheel and Lymphomyosot (the latter also orally), in alternating injections every 1-2 days. Glyoxal compositum, in general, should be interposed only when improvement flags. See also ”Dedifferentiation Phases”, page 49. As alternating remedies, Para-Benzochinon-Injeel and cAMP D30 are to be considered primarily.
The dosage is adjusted according to the disease, the clinical picture and the stage of the illness.